Gain Therapeutics is a preclinical stage biotech company.
Gain Therapeutics has raised €2.5M across 1 funding round from 3 investors, most recently a Series A round in Jan 2019. Based in Lugano, Switzerland; founded 2017; active in Fintech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-01-01 | Series A |
| €2.5M |
| Helsinn Investment Fund,Triventures,VitaTech S.A |
| View deal → |
